A Summary of the ADVANCE Trial
Open Access
- 1 November 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (suppl_2), S357-S361
- https://doi.org/10.2337/dc09-s339
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 DiabetesNew England Journal of Medicine, 2007
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Lymphocytic Infundibuloneurohypophysitis as a Cause of Central Diabetes InsipidusNew England Journal of Medicine, 1993
- Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1992